SGS SA (SGSN.SW) - Deep Dive Research Report

Sector: Industrials (Testing, Inspection & Certification) | Listing: SIX Swiss Exchange | Report date: 2026-06-09 Reporting periods used: FY2025 (11 Feb 2026), Q3 2025 trading update (Oct 2025), H1 2025 (25 Jul 2025), Q1 2025 trading update (24 Apr 2025), FY2024 (Feb 2025)

1. What the company does

SGS gets paid to tell people whether something is what it claims to be. A trader buying a shipload of iron ore wants to know the metal content before money changes hands. A toy importer needs proof that a children's product will not poison or choke a child before a retailer will stock it. A pharmaceutical company needs an independent lab to confirm a drug batch meets specification. A factory wants an auditor to certify its quality-management system to ISO 9001 so its customers will trust it. SGS is the third party in the middle of all of these transactions: it tests, inspects, certifies, and verifies, and the value of its signature comes entirely from the fact that it has no stake in the outcome.

The business is old. It was founded in 1878 in Rouen, France, as the Société Générale de Surveillance, originally to inspect and weigh grain shipments in European ports so that buyers and sellers could settle trades without trusting each other. That founding logic - an independent referee who reduces the cost of distrust between two commercial parties - is still the entire business 148 years later. The company moved its headquarters to Geneva, Switzerland, in 1915, and today it is the largest of the global testing, inspection and certification (TIC) companies, with roughly 100,000 employees and a network of more than 2,500 offices and laboratories across over 115 countries.

The core value proposition is trust at a distance. Global trade and regulated markets only work if a buyer in Rotterdam can rely on a quality claim about goods made in Shenzhen, or a regulator in Brussels can rely on a safety test run in Vietnam. SGS exists to make those claims credible. What makes the service hard to replicate is not any single test - it is the combination of (1) accreditation, the formal recognition by national and international bodies that an SGS laboratory is competent to issue a given certificate, (2) a physical footprint of labs and inspectors near where goods are made and shipped, and (3) a 148-year-old brand whose stamp is recognised by customs authorities, retailers and regulators worldwide. A new entrant can buy lab equipment in a week; it cannot manufacture accreditation, density of coverage, or a reputation that customs officers already trust.

A concrete example: a European electronics brand wants to sell a new wireless earbud globally. Before it ships a single unit, it sends prototypes to an SGS Connectivity & Products lab. SGS runs electrical-safety tests, radio-frequency and electromagnetic-compatibility testing to confirm the device will not interfere with other equipment, battery-safety testing, and checks against the specific regulatory regimes of every market the brand wants to enter - FCC in the US, CE marking in Europe, and dozens of national wireless certifications. SGS issues the test reports and certificates that let the product clear customs and reach shelves. The brand pays SGS a fee per product and per market, and comes back with every new model. SGS never owns the product, never sells it, and never carries inventory risk - it sells the credibility of its signature, repeatedly, at high margin.

2. Business segments

Under "Strategy 27: Accelerating growth, building trust," SGS reorganised in 2024 into two divisions and began reporting Testing & Inspection and Certification results separately. Testing & Inspection is run through five regions because the work is inherently local (you cannot test cargo in Singapore from Geneva), and it contains four operating segments. Certification is run as a single global activity called Business Assurance. The five reporting segments below are the way to understand the group.

Industries & Environment (~32% of group sales - the largest segment)

This is the infrastructure and industrial-safety engine. It does non-destructive testing of welds and pipelines, inspection of construction and civil works, health, safety and environmental (HSE) services, environmental-compliance testing (soil, water, air, emissions), and asset-integrity work for power, transport and industrial plants. The customer is typically an industrial operator, an engineering contractor, or a government infrastructure body. The core capability is a field workforce of qualified inspectors and engineers who can be deployed on site, combined with environmental laboratories. It competes against Bureau Veritas (strong in construction and infrastructure) and Applus. Management talks about this as a structural growth segment riding infrastructure spend, energy-transition projects, and - newly emphasised in 2025 - European data-centre construction. In Q3 2025 it was the fastest accelerating segment at 7.9% organic growth (up from 5.3% in H1 2025).

Natural Resources (~22% of group sales)

This segment serves the extractive and agricultural commodity chains: minerals and metals testing for miners and traders, oil/gas/chemicals inspection and laboratory testing, and agricultural inspection and testing (grain, soft commodities). This is the lineal descendant of the original 1878 grain-inspection business. The core capability is a global network of minerals labs and cargo inspectors positioned at mines, ports and trading hubs, plus deep analytical chemistry. The structural new driver here is critical minerals: SGS has flagged double-digit growth in battery-metals testing (lithium, cobalt, nickel) in the Americas, riding the EV and energy-storage build-out. It is the most cyclical and commodity-price-sensitive segment - growth was a soft 2.9% in H1 2025 before recovering to 4.4% in Q3 2025. Competitors include Bureau Veritas, Intertek, and the specialist minerals-testing firm ALS (Australia).

Connectivity & Products (~20% of group sales)

This is the consumer-and-electronics testing and certification segment: electrical and electronic product safety, wireless/RF and EMC testing, cybersecurity and "digital trust" services, softlines and hardlines consumer-goods testing (toys, textiles, footwear), and government inspection programmes. The customer is a manufacturer or brand that needs market access. The core capability is a dense lab network in Asia (where the products are made) plus accreditation across hundreds of national regulatory regimes. This is where SGS's strategically prioritised Digital Trust franchise sits - cybersecurity testing, product-security certification, and connected-device assurance - which management says reached roughly CHF 350 million of sales in 2025 and is growing about 20% a year. It competes against Intertek (consumer goods), UL Solutions (US, very strong in electrical safety), and TÜV SÜD/Rheinland.

Health & Nutrition (~13% of group sales)

This segment serves regulated life-science and food markets: food-safety testing and audits, crop-science and agrochemical testing, pharmaceutical and health-science laboratory and clinical-research services, and cosmetics and personal-care testing. The customer is a food producer, retailer, pharma company, or cosmetics brand operating under strict regulation. The core capability is accredited specialist labs and clinical-research expertise. This was the standout grower in 2025 - 10.4% organic in Q1 and 8.9% in H1 - driven by food, nutraceuticals/dietary-supplement certification, pharma, and cosmetics. It is the segment most directly exposed to Eurofins Scientific, the aggressive Luxembourg-based food-and-life-science testing consolidator. Management frames Health & Nutrition as a structural growth bet tied to "customer awareness and well-being" megatrends.

Business Assurance / Certification (~13% of group sales)

This is the standalone Certification division, run globally. It certifies management systems (ISO 9001 quality, ISO 14001 environmental, ISO 45001 safety, information-security standards), runs customised second-party audits of suppliers, provides sustainability and ESG assurance, and operates a training arm (SGS Academy) and a consulting practice. The customer is any organisation that needs an accredited certificate to win business or satisfy a regulator. The economics are attractive: certification is recurring (annual surveillance audits over multi-year cycles) and asset-light. This is where the Sustainability franchise (roughly CHF 1 billion of group sales in 2025) is concentrated. Management has set this segment a specific target of 10% organic growth and a margin above 20% by 2026 - the highest-margin ambition in the group. It competes against Bureau Veritas Certification, Intertek, TÜV, DNV and DEKRA.

Segment summary

3. Products and business detail

SGS's "products" are reports, certificates and seals, but each rests on specific technical capability and accreditation. The catalogue spans four activities that recur across all five segments:

Testing is laboratory analysis. In minerals, that means fire-assay and ICP analysis to determine ore grade; in food, microbiology, pesticide-residue and allergen testing; in consumer products, mechanical safety, flammability and chemical-content testing against regulations such as REACH and CPSIA; in electronics, electrical-safety, battery and RF/EMC testing. Each test type requires a laboratory accredited to a specific standard (ISO/IEC 17025 for testing labs is the baseline), and accreditation is granted lab-by-lab, method-by-method, by national bodies. That accreditation is the real product - it is what makes the test report acceptable to a customs authority or regulator.

Inspection is physical verification, usually in the field: checking the quantity and quality of a commodity cargo before loading, inspecting a weld on a pipeline, supervising the fumigation of a grain shipment, or verifying that a construction project meets code. This requires a deployable workforce of qualified inspectors near ports, mines, factories and project sites - the asset is people and location, not equipment.

Certification is the periodic audit of a management system against a published standard, ending in an accredited certificate (e.g. ISO 9001). The work is recurring by design: a three-year certification cycle with annual surveillance audits, which gives this activity the most predictable revenue in the group.

Verification confirms that a claim is true - increasingly sustainability and ESG claims (carbon footprints, supply-chain due diligence, green-bond use of proceeds), which is the fast-growing edge of the certification business.

The two franchises management singles out are cross-cutting product lines rather than segments. Sustainability (~CHF 1 billion of 2025 sales, IMPACT NOW initiative) bundles ESG assurance, carbon verification, and supply-chain audits across all segments. Digital Trust (~CHF 350 million of 2025 sales) bundles cybersecurity testing, connected-device security certification and data-integrity services, concentrated in Connectivity & Products. Both are growing roughly 20% a year and carry attractive economics because they ride regulation rather than the industrial cycle.

Geographically, SGS is genuinely global: testing labs cluster in Asia near manufacturing, minerals and agri inspection cluster at ports and resource basins, and certification and environmental work follow regulated developed markets. The structural geographic project under Strategy 27 is North America. SGS has been under-indexed in the US relative to its global scale, and the 2025 acquisition of Applied Technical Services (ATS) - enterprise value $1.325 billion, about $460 million of revenue split across inspection (41%), calibration (22%), forensic consulting (22%) and testing (15%) - was the centrepiece move. Management said the deal, combined with bolt-ons and organic growth, brings SGS "very close" to its goal of doubling North American sales by 2027 (H1 2025 concall).

4. Customers

SGS's customers fall into four broad buckets, and the buying relationship differs in each.

Manufacturers and brands (electronics, consumer goods, food, cosmetics, pharma) buy product testing and certification because they cannot sell into a market without it. The buyer is usually a quality/regulatory-affairs or compliance manager, and the decision criterion is market access: does this lab's accreditation let my product clear customs and satisfy the retailer's onboarding requirements? The sales cycle is short for routine testing and longer for a new global product launch, but the relationship is sticky and repeat - every new product model means a new test.

Commodity producers and traders (miners, oil/gas, agricultural traders) buy inspection and assay because a cargo will not be paid for without an independent quality-and-quantity certificate. The buyer is a trading or operations desk, and the decision is driven by which inspector both counterparties to the trade will accept - a network effect that favours the incumbent with the widest port coverage.

Industrial and infrastructure operators buy NDT, asset-integrity and environmental services, often under multi-year framework contracts, where the buyer is an engineering or HSE function and the criteria are technical competence and safety record.

Any regulated organisation buys management-system and sustainability certification, where the buyer is senior management and the decision is which certification body's mark carries the most weight with their own customers and regulators.

The switching costs are real but quiet. They come from accreditation and qualification: once a customer's product, process or supplier has been qualified through SGS's accredited methods, re-qualifying through a competitor costs time, money and regulatory risk. In certification, switching certification bodies mid-cycle is disruptive and can raise questions with the customer's own clients. In commodity inspection, both sides of a trade have to agree on the inspector, so incumbency compounds. None of these are absolute locks - this is a competitive, fragmented industry - but they make revenue durable and churn low.

Customer concentration is essentially nil, which is itself a structural strength. SGS serves hundreds of thousands of customers across every industry and geography; no single customer or end-market can break the company. Contract structure is a healthy mix: recurring certification and framework-contract revenue gives a predictable base, while transactional testing and inspection volumes flex with trade and industrial activity. The recurring share has been rising as Sustainability and certification grow faster than the cyclical commodity-inspection work.

5. Competitive landscape

The TIC industry is large and strikingly fragmented. The global market is estimated at roughly USD 250 billion in 2026, growing around 3.8% a year, and the top five players together hold less than 15% of it. The reason is structural: TIC is thousands of distinct accredited niches (every test method in every regulated market is its own little market), so no firm can dominate across the board, and roughly 60% of all testing is still done in-house or in government labs rather than outsourced to private providers - a long runway for the listed players to take share.

SGS is the largest TIC company by revenue (around USD 7.7 billion). Its edges are scale, the densest global lab-and-inspection network, the broadest accreditation portfolio, and a 148-year-old brand that customs and regulators already trust. Where it is exposed: it has historically been under-weight in the United States (the ATS acquisition is the fix), and in pure food-and-life-science testing it faces Eurofins, a faster-moving consolidator that has out-acquired everyone in that niche.

A defining recent event frames the competitive structure: in January 2025, SGS and Bureau Veritas confirmed they had held talks about a roughly USD 30 billion merger that would have created a TIC company larger than the rest of the field combined - and then walked away without agreement within weeks. The episode tells you two things: the industry's two largest players see consolidation logic, and the practical and political obstacles (including complications around a Swiss-EU listing) are high enough to have killed the biggest possible deal. SGS has since pursued consolidation the harder way, through bolt-on M&A (14 acquisitions in 2024, five more in Q3 2025) plus the ATS platform deal.

The barriers to entry are moderate-to-high and built from accreditation, network density, brand trust and capital, but they are not absolute - margins are healthy rather than monopolistic, and the field stays competitive precisely because the market is fragmented into thousands of niches. SGS's moat is best described as scale and trust accumulated over a century, not a technological lock.

6. Industry

Demand for TIC is driven by four forces that are mostly secular rather than cyclical. First, regulation: every new safety, environmental, food-safety or product standard creates testing and certification work, and the regulatory ratchet only tightens. Second, global trade complexity: the more goods cross borders and the longer the supply chain, the more independent verification is needed at each handoff. Third, technology and product complexity: connected devices, EVs, batteries and new materials all need new test regimes (this is the Digital Trust and battery-metals tailwind). Fourth, the sustainability and ESG wave: carbon verification, supply-chain due-diligence audits and green-claim assurance are an entirely new demand category that barely existed a decade ago and is now a roughly CHF 1 billion line for SGS alone.

The market is large (~USD 250 billion in 2026) and grows in a low-single-digit to mid-single-digit band (~3.8% CAGR on third-party estimates), with the listed leaders growing faster than the market by taking outsourcing share. The single most important structural fact is the outsourcing runway: only about 40% of testing is currently done by private TIC providers, with the other ~60% sitting in corporate in-house labs and government facilities. As regulation tightens and companies prefer to transfer compliance risk to an accredited third party, that in-house share migrates outward, and the listed players are the natural beneficiaries.

SGS sits in the middle of the global supply chain as a neutral intermediary - it touches goods at the point of manufacture (Asian labs), at shipment (port inspectors), at import (customs-recognised certificates), and through the product's regulated life (certification surveillance). The regulatory environment is both the demand driver and the barrier to entry: accreditation bodies, government conformity-assessment programmes, and mutual-recognition agreements decide who is allowed to issue a valid certificate, and that gatekeeping protects incumbents.

Cyclicality is moderate and uneven across segments. Certification, environmental and food/health testing are defensive and tied to regulation. Natural Resources (commodity inspection) is the cyclical part, geared to commodity volumes and capex. Industries & Environment flexes with infrastructure and industrial activity. The blended result is a business that grows through the cycle with low single-digit downside risk in a recession rather than the deep cyclicality of a pure industrial. The main headwind at the industry level is currency translation for a Swiss-franc reporter (a strong franc depresses reported sales even when organic growth is solid - exactly what happened in 2025, when 5.6% organic growth became only 2.2% reported growth after forex).

7. Growth triggers

All points below are drawn from the five most recent reporting calls.

• North America scale-up via the ATS acquisition. SGS completed Applied Technical Services (EV $1.325bn, ~$460m revenue) to deepen its under-weight US presence (H1 2025 concall, 25 Jul 2025).

  "This deal combined with bolt on acquisitions and organic growth in the region brings us very close to our initial objective to double the sales in North America in 2027." (H1 2025)

• Digital Trust as a ~20%-growth franchise. Cybersecurity and connected-device assurance reached roughly CHF 350m of 2025 sales and is repeatedly flagged as a priority (H1 2025; Q3 2025; FY2025).

  "Our unique competencies in digital trust are one of the most valuable assets of the group." (Q3 2025 concall)

• Sustainability franchise crossing CHF 1bn. ESG assurance, carbon verification and supply-chain audits (IMPACT NOW) reached at least CHF 1bn of 2025 sales, growing ~20% (FY2025, 11 Feb 2026; first scaled in FY2024).

• Critical minerals and EV/battery-metals testing. Double-digit growth in battery-metals testing in the Americas; strong demand in critical minerals and EV sectors (Q1 2025, 24 Apr 2025; Q3 2025).

• Supply-chain diversification away from China. Re-shoring and "China+1" sourcing is generating new testing and inspection volumes (Q3 2025 concall).

• European data-centre construction. Named as a new driver inside Industries & Environment, which accelerated to 7.9% organic in Q3 (Q3 2025 concall).

• Business Assurance margin step-up. Management targets 10% organic growth and a margin above 20% in Business Assurance by 2026 (Q3 2025 concall).

• Continued bolt-on M&A cadence. 14 bolt-ons integrated in 2024 and five completed in Q3 2025, with North America the priority (FY2024, Feb 2025; Q3 2025).

• Cybersecurity, AI and life-science megatrends into 2026. Management framed 2026 growth around cybersecurity/AI (Digital Trust) and "customer awareness and well-being" (Health & Nutrition / life science), with more detail promised at a capital-markets event (FY2025 concall, 11 Feb 2026).

8. Key risks

Currency translation is a structural, recurring drag. SGS reports in Swiss francs but earns most revenue in dollars, euros, yuan and emerging-market currencies. A strong franc converts healthy organic growth into weak headline growth. This is not hypothetical: in 2025, 5.6% organic growth and good M&A contribution were cut to just 2.2% reported sales growth by adverse forex. The mechanism hurts reported EPS, the dividend-paying capacity in francs, and the share-price optics, even when the underlying business is performing. It is a high-probability, moderate, perennial headwind rather than a one-off.

Natural Resources is geared to the commodity cycle. Roughly a fifth of the group depends on mining and oil/gas volumes and capex. A sustained downturn in commodity prices slows inspection and assay volumes - visible in the soft 2.9% organic growth this segment posted in H1 2025 before recovering. A deeper, longer commodity recession would be a real drag on group growth and is partly outside management's control.

M&A integration and overpayment risk. Strategy 27 leans on acquisitions, headlined by the $1.325bn ATS deal plus dozens of bolt-ons. The bull case assumes $30m of ATS synergies within three years and clean integration. TIC roll-ups can disappoint if integration is messy, if acquired accreditations or key people leave, or if competition for assets (Eurofins, Bureau Veritas and private equity are all buyers) inflates prices. A botched large deal would dent both growth and the margin story.

A new CEO executing a still-young strategy. Géraldine Picaud became CEO in 2024 (from the Holcim CFO seat), and Strategy 27 and the divisional reorganisation are her programme. So far execution has been strong, but the strategy is only partway through, and the credibility built over five clean quarters is not yet a multi-cycle track record. Leadership-transition execution risk is moderate and declining but real.

Failed consolidation leaves SGS competing on its own. The collapse of the Bureau Veritas merger in January 2025 means SGS does not get the scale step-change a combination would have delivered, while a well-funded Eurofins keeps consolidating life-science testing and private equity competes for assets. The risk is slow erosion of relative position in specific high-growth niches (notably food/life science) rather than a sudden break.

A trust event is the tail risk specific to this business model. SGS sells the credibility of its signature. A high-profile failure - a certified product that proves unsafe, a falsified test, or an inspection scandal - directly attacks the one asset that cannot be quickly rebuilt: trust. This is a low-probability but potentially severe risk, and it is structural to every TIC company, not just SGS.

9. Walk the talk

The five calls used are FY2024 (Feb 2025), Q1 2025 (24 Apr 2025), H1 2025 (25 Jul 2025), Q3 2025 (Oct 2025) and FY2025 (11 Feb 2026). The most recent is within ~90 days of today. Across these five periods, management set specific, checkable targets and then hit or beat them with unusual consistency.

At FY2024, with Strategy 27 freshly in place, management guided 2025 to strong organic growth, continued margin progression, and strong cash generation, against a Strategy 27 framework of 5-7% organic growth and a margin rising toward 16.2% by 2027. The 2025 guidance was set explicitly at 5-7% organic growth with at least 30 basis points of margin improvement.

The quarterly cadence delivered against that guide almost mechanically. Q1 2025 printed 5.6% organic growth and management reaffirmed the 5-7% range. H1 2025 came in at 5.3% organic (with management noting Q2 would be the weakest quarter of the year), and crucially the margin jumped 80bps to 14.9% - well ahead of the "at least 30bps" full-year promise - because the corporate-simplification programme front-loaded its savings.

"Corporate simplification delivered CHF 96 million in cumulative savings against a CHF 100 million target ... the procurement efficiency plan is 70% secured, with completion expected by year-end." (H1 2025)

That is a kept promise with the receipts attached. Q3 2025 then accelerated to 6% organic, with the CFO stating "our nine-month sales are fully aligned with our full-year guidance," and the CEO reaffirming "at least 30 basis points" of margin improvement and strong free cash flow.

The full-year result validated the whole sequence. FY2025 delivered 5.6% organic growth (squarely inside the 5-7% guide), an adjusted operating margin of 16.0% - up 70bps, more than double the "at least 30bps" promise - record free cash flow of CHF 841m, and record EPS of CHF 3.48. The most striking point: the 16.0% margin essentially reaches the Strategy 27 target of ~16.2% by 2027 two years early. Management did what it said on growth and beat what it said on margin.

The honest caveat: this is a young track record. Picaud's tenure and Strategy 27 are barely two years old, the period coincided with a benign demand environment, and the 2027 North-America-doubling and Business-Assurance >20%-margin promises are not yet proven out. But on every checkable commitment across five consecutive periods, management delivered or over-delivered, and it under-promised on margin and beat. The plain assessment: this is management that does what it says, with a tendency to set conservative margin targets and exceed them.

10. Shareholder friendliness index

Dividends. SGS is a long-standing, reliable dividend payer with a 25-year payment history and no cut in 15 years. A share split in 2024 re-based the per-share figures (the FY2023 dividend was CHF 80 on the old share count), so on a comparable post-split basis the ordinary dividend has been held flat at CHF 3.20 per share for FY2024 and CHF 3.20 for FY2025 (proposed and confirmed at the 2026 AGM, with a scrip-or-cash option that shareholders took ~61% in shares). Holding the dividend flat while EPS rose to CHF 3.48 in 2025 implies a payout ratio comfortably below 100% and falling - the dividend is well covered and the flat headline reflects franc-translation conservatism rather than weakness. (Sources: SGS dividend page; 2025 full-year results, 11 Feb 2026; Dividend 2025 Announcement of Final Terms, Apr 2026.)

Buybacks and dilution. SGS's most recent buyback was a CHF 250 million programme that ran from June to December 2022 for capital reduction, with the repurchased shares cancelled at the 2023 AGM. There have been no new buyback programmes in 2023, 2024 or 2025, and the MoatMap database shows zero buybacks in the trailing ~90 days (since 11 Mar 2026) - consistent with the company's current preference for cash dividends plus M&A over repurchases. Share count is not shrinking; if anything it drifts modestly upward because the scrip-dividend option issues new shares to electing holders (61% of the 2025 dividend was taken in stock), a mild dilution offset by the larger cash retained for acquisitions. So the recent capital-return picture is dividend-led, not buyback-led.

Verdict: Returns Capital (dividend-led, no recent buybacks) - a dependable, flat-to-growing cash dividend backed by record free cash flow, with surplus capital directed to bolt-on and platform M&A rather than repurchases.

11. Insider activities

The listing venue is the SIX Swiss Exchange, where management transactions are reportable under Art. 56 of the SIX Listing Rules and published (anonymised by role) through the SIX Exchange Regulation register. The MoatMap database is the spine for this section; I have read the transactions in the context of SGS's corporate calendar.

(Source: SIX Exchange Regulation management-transactions register, via MoatMap, data current 2026-06-09.)

Read the signal carefully - most of this is mechanical, not conviction. The cluster of "buys" dated 2026-04-27/28 is almost entirely priced at exactly CHF 81.36, which is the precise distribution value SGS set for new shares under its 2025 scrip dividend (reference price CHF 85.64, less a 5% discount = CHF 81.36, paid 24 Apr 2026). These are insiders electing to take their dividend in shares rather than cash, reported through the SIX register as acquisitions. They are not open-market conviction purchases and should not be read as a bullish cluster. The one buy at CHF 74.318 in the same batch is likely a related scrip/exercise mechanic at a different reference.

The genuinely informative transaction is the 2026-03-23 open-market purchase of 1,500 shares at CHF 84.04 (~CHF 126,000) by an executive board / senior-management insider, executed roughly six weeks after the strong FY2025 results and outside any scrip mechanic. That is a real, mid-six-figure open-market buy by a senior insider - a mildly positive signal, though sized as a meaningful-but-not-enormous personal commitment rather than a dramatic, career-defining bet.

Net assessment. Over the last 12 months the SIX register shows only buys and no sells, which is directionally reassuring - no insider was reducing exposure. But the headline "12 buys, net buying" overstates the conviction content, because nine of the twelve are scrip-dividend elections at the fixed CHF 81.36 distribution price. Stripping those out, the substantive signal is a single genuine open-market purchase by a senior executive in March 2026. The honest read is neutral-to-mildly-positive: no insider selling (good), but no large discretionary open-market accumulation either. Note also that SIX publishes these by role, not by name, so the specific individuals cannot be identified from the register.

12. Scenarios

Bull case. Strategy 27 proves to be exactly what management said, and then some. The ATS platform integrates cleanly, captures its $30m of synergies, and North American sales double on schedule by 2027, finally giving SGS the US weighting its global scale deserved. Digital Trust and Sustainability keep compounding at ~20%, turning two start-up franchises into a multi-billion-franc growth core that re-rates the whole company away from "cyclical industrial inspector" toward "regulation-and-trust compounder." Business Assurance hits its >20% margin target, dragging group margin past the 16.2% Strategy 27 goal it already nearly reached two years early. Critical-minerals, EV-battery, data-centre and China+1 testing volumes all run hot together. The franc behaves, so strong organic growth finally shows up in reported numbers, and the dividend grows again off record free cash flow. SGS ends the period as the unambiguous scale leader of a consolidating industry, having achieved through disciplined bolt-ons what the Bureau Veritas mega-merger could not.

Base case. Management keeps doing roughly what it has done for five straight quarters: 5-7% organic growth, steady 30-70bps of annual margin improvement, record free cash flow, and a flat-to-slowly-growing dividend. ATS and the bolt-ons integrate without drama and contribute as guided, North America gets close to the doubling target even if not perfectly on time, and Digital Trust and Sustainability stay the fastest-growing lines without single-handedly transforming the group. Natural Resources stays lumpy with the commodity cycle but doesn't break anything. The franc keeps clipping reported growth below organic growth, so the headline looks less exciting than the underlying business. SGS remains the largest TIC company, executes competently, and compounds at a respectable mid-single-digit organic pace with gradual margin gains - a steady, defensive, dividend-paying industrial.

Bear case. Several things go soft at once. A commodity downturn drags Natural Resources back toward zero growth, the franc strengthens further and pushes reported growth close to flat, and Europe (already the weakest region at ~1% in H1 2025) stays sluggish. The ATS integration disappoints - synergies slip, key forensic-consulting and calibration staff leave, and the North-America-doubling target quietly fades from the script. Eurofins keeps out-acquiring SGS in the high-growth food and life-science niches, and with the Bureau Veritas merger dead, SGS lacks the scale step-change to respond. Margin progress stalls short of the 2027 target as cost savings run out and price competition bites in commoditised inspection lines. In the tail, a high-profile certification or testing failure damages the brand's core asset - trust - and forces remediation that hits both reputation and margin. None of this is a solvency threat, but the combination would turn a reliable compounder into a stalled, ex-growth industrial whose flat dividend is the main thing holding the stock.

Sources

• SGS 2025 Full Year Results - Record Financial Performance
• SGS 2025 Full Year Results page
• SGS H1 2025 results press release (PDF)
• SGS Q3 2025 earnings call transcript - Investing.com
• SGS H1/Q2 2025 earnings call transcript - Investing.com
• SGS Q1 2025 presentation slides - Investing.com
• SGS FY2024 earnings call transcript - Seeking Alpha
• SGS FY2025 earnings call transcript - GuruFocus
• Géraldine Picaud announces new Executive Committee - SGS
• TIC market size & leaders - MarketsandMarkets
• TIC industry guide - Aventis Advisors
• SGS and Bureau Veritas end merger talks - MarketScreener
• SGS Dividend page
• SGS Dividend 2025 - Announcement of Final Terms
• SGS announces 2022 share buyback program
• SGS ends 2022 share buyback program
• Bureau Veritas market cap - companiesmarketcap.com
• Intertek market cap - companiesmarketcap.com
• Eurofins Scientific market cap - companiesmarketcap.com

A note on what I could not fully verify: the FY2023 adjusted operating margin (14.7%) in the margin chart is inferred from the disclosed +60bps FY2024 improvement to 15.3%; segment revenue-mix percentages are approximations triangulated from Q1 2025 segment sales (the exact FY2025 mix was in the press-release PDF, which returned HTTP 403). Section 13 (Further Reading) is omitted because no qualifying SemiAnalysis, Stratechery, or MBI Deep Dives coverage of SGS exists - all three focus on tech/semis, outside this company's TIC remit.